Published in Circulation on November 01, 1994
Venous-arterial extracorporeal membrane oxygenation for refractory cardiac arrest: a clinical challenge. Eur Heart J Acute Cardiovasc Care (2013) 1.16
Emergency cardiopulmonary bypass support in patients with severe cardiogenic shock after acute myocardial infarction. Heart Vessels (1996) 0.97
Fibrin glue: an effective hemostatic agent for nonsuturable intraoperative bleeding. Ann Thorac Surg (1984) 2.07
Tranexamic acid significantly reduces blood loss associated with coronary revascularization. Ann Thorac Surg (1995) 1.44
Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation (1999) 1.43
Postischemic deterioration of sarcoplasmic reticulum: warm versus cold blood cardioplegia. Ann Thorac Surg (1993) 1.39
Protective role of intracoronary fatty acid binding protein in ischemic and reperfused myocardium. Circ Res (1990) 1.39
Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun (1987) 1.29
Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol (2001) 1.29
Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res (1999) 1.28
Targeted disruption of the mouse Sod I gene makes the hearts vulnerable to ischemic reperfusion injury. Circ Res (2000) 1.24
Mediastinitis following open-heart surgery. Review of two years' experience. Arch Surg (1973) 1.19
Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. J Mol Cell Cardiol (1996) 1.17
Postpneumonectomy esophageal fistula: successful one-stage repair. J Thorac Cardiovasc Surg (1970) 1.16
Esophagogastrostomy. Analysis of 55 cases. J Thorac Cardiovasc Surg (1975) 1.15
Myocardial protection with red wine extract. J Cardiovasc Pharmacol (2000) 1.14
Epicardial activation of the intact human heart without conduction defect. Circulation (1979) 1.13
The long-term influence of coronary bypass grafts on myocardial infarction and survival. Ann Surg (1974) 1.13
Aneurysm of aberrant right subclavian artery. Rare cause of superior mediastinal tumor. N Y State J Med (1973) 1.10
Thoracic aortic dissection following cannulation for perfusion. Ann Thorac Surg (1974) 1.10
Fast-track recovery of the coronary bypass patient. Ann Thorac Surg (1994) 1.10
Newcastle thyrotoxicosis index. Lancet (1970) 1.09
Is there a relationship between systemic perfusion temperature during coronary artery bypass grafting and extent of intraoperative ischemic central nervous system injury? J Thorac Cardiovasc Surg (2000) 1.08
Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. Cardiovasc Res (1993) 1.05
Phrenic nerve paresis associated with the use of iced slush and the cooling jacket for topical hypothermia. J Thorac Cardiovasc Surg (1985) 1.02
Glutathione peroxidase knockout mice are susceptible to myocardial ischemia reperfusion injury. Circulation (1997) 1.00
Determinants of compliance in rheumatoid arthritic patients assessed in their home environment. Br J Rheumatol (1985) 1.00
Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am J Physiol (1986) 0.98
Functional capacity and treatment data from a community based study of patients with rheumatoid arthritis. Ann Rheum Dis (1986) 0.97
Risk of dysphagia after transesophageal echocardiography during cardiac operations. Ann Thorac Surg (2000) 0.97
Programmed instruction in medical education. Comparison of teaching-machine and programmed textbook. Br J Med Educ (1967) 0.96
Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res (1995) 0.95
The 'primeless pump': a novel technique for intraoperative blood conservation. Cardiovasc Surg (1999) 0.95
Oxygen free radical signaling in ischemic preconditioning. Ann N Y Acad Sci (1999) 0.95
The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res (1996) 0.94
Experience with open mitral commissurotomy in 100 consecutive patients. Surgery (1974) 0.94
Hyperosomolar coma in surgical patients: an latrogenic disease of increasing incidence. Ann Surg (1973) 0.94
Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation (1993) 0.92
Myocardial adaptation to ischemia by oxidative stress induced by endotoxin. Am J Physiol (1995) 0.91
L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion. Ann Thorac Surg (1995) 0.91
Coronary artery bypass with freeze-preserved saphenous vein allografts. J Thorac Cardiovasc Surg (1976) 0.90
Nitric oxide/carbon monoxide. A molecular switch for myocardial preservation during ischemia. Circulation (1996) 0.90
Transatrial repair of postinfarction posterior ventricular septal defect. Ann Thorac Surg (1987) 0.90
Complications of ventriculoatrial shunting for hydrocephalus requiring cardiac operation. Ann Thorac Surg (1969) 0.90
Coordinated role of vasoactive intestinal peptide and nitric oxide in cardioprotection. Ann N Y Acad Sci (1998) 0.89
Blood conservation for myocardial revascularization. Is it cost effective? J Thorac Cardiovasc Surg (1987) 0.89
Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch Trial. Circulation (2000) 0.89
Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures. J Thorac Cardiovasc Surg (1983) 0.89
Pathophysiology of superoxide radical as potential mediator of reperfusion injury in pig heart. Basic Res Cardiol (1986) 0.88
Nitric oxide--a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol Cell Biochem (1996) 0.88
Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Circulation (2000) 0.88
Use of extrafascially harvested radial artery for coronary artery revascularization: technical considerations. J Card Surg (2000) 0.88
Safety of prolonged ischemic arrest using hypothermic cardioplegia. J Thorac Cardiovasc Surg (1980) 0.88
Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem (1998) 0.88
Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers. J Mol Cell Cardiol (1991) 0.87
Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. Control of its production by a phospholipase inhibitor or free radical scavengers. J Mol Cell Cardiol (1986) 0.87
Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg (1995) 0.87
Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. Circulation (1993) 0.87
Estimation of the extent of lipid peroxidation in the ischemic and reperfused heart by monitoring lipid metabolic products with the aid of high-performance liquid chromatography. J Chromatogr (1993) 0.86
Effects of free radicals on the fluidity of myocardial membranes. Free Radic Res Commun (1989) 0.86
Traumatic ventricular septal defect following closed-chest massage: a new approach to closure. Ann Thorac Surg (1984) 0.86
Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J Pharmacol Exp Ther (1993) 0.86
Drug-induced heat-shock preconditioning improves postischemic ventricular recovery after cardiopulmonary bypass. Circulation (1995) 0.85
Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. J Pharmacol Exp Ther (1998) 0.85
Nonthrombogenic aortic and vena caval bypass using heparin-coated tubes. Am J Surg (1974) 0.85
Alpha-1 adrenergic receptor agonist-induced preconditioning in isolated working rat hearts. J Pharmacol Exp Ther (1995) 0.84
Retrograde continuous warm blood cardioplegia. Ann Thorac Surg (1991) 0.84
Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers. J Thorac Cardiovasc Surg (1986) 0.84
Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg (1995) 0.83
The role of protein kinase in C ischemic/reperfused preconditioned isolated rat hearts. J Cardiovasc Pharmacol (1996) 0.83
Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury. J Thorac Cardiovasc Surg (1986) 0.83
Routine operative arteriography following vascular reconstruction. Surg Gynecol Obstet (1969) 0.83